|
1) Iddan G, Meron G, Glukhovsky A, et al. Wireless capsule endoscopy. Nature. 2000; 405: 417
|
|
|
|
|
2) Yamamoto H, Sekine Y, Sato Y, et al. Total enteroscopy with a nonsurgical steerable double-balloon method. Gastrointest Endosc. 2001; 53: 216-20
|
|
|
|
|
3) Bjarnason I, Takeuchi K. Intestinal permeability in the pathogenesis of NSAID-induced enteropathy. J Gastroenterol. 2009; 44 Suppl 19: 23-9
|
|
|
|
|
|
4) Watanabe T, Higuchi K, Kobata A, et al. Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent. Gut. 2007; 57: 181-7
|
|
|
|
|
|
5) Satoh H, Shiotani S, Otsuka N, et al. Role of dietary fibres, intestinal hypermotility and leuko-trienes in the pathogenesis of NSAID-induced small intestinal ulcers in cats. Gut. 2009; 58: 1590-6
|
|
|
|
|
|
6) Iwai T, Ichikawa T, Goso Y, et al. Effects of indomethacin on the rat small intestinal mucosa: immunohistochemical and biochemical studies using anti-mucin monoclonal antibodies. J Gastroenterol. 2009; 44: 277-84
|
|
|
|
|
7) Meyer-Hoffert U, Hornef MW, Henriques-Normark B, et al. Secreted enteric antimicrobial activity localises to the mucus surface layer. Gut. 2008; 57: 764-71
|
|
|
|
|
|
8) Endo H, Hosono K, Inamori M, et al. Characteristics of small bowel injury in symptomatic chronic low-dose aspirin users: the experience of two medical centers in capsule endoscopy. J Gastroenterol. 2009; 44: 544-9
|
|
|
|
|
|
9) Endo H, Hosono K, Inamori M, et al. Incidence of small bowel injury induced by low-dose aspirin: a crossover study using capsule endoscopy in healthy volunteers. Digestion. 2009; 79: 44-51
|
|
|
|
|
|
10) Smecuol E, Pinto Sanchez MI, Suarez A, et al. Low-dose aspirin affects the small bowel mucosa: results of a pilot study with a multidimensional assessment. Clin Gastroenterol Hepatol. 2009; 7: 524-9
|
|
|
|
|
|
11) Matsumoto T, Kudo T, Esaki M, et al. Prevalence of non-steroidal anti-inflammatory drug-induced enteropathy determined by double-balloon endoscopy: a Japanese multicenter study. Scand J Gastroenterol. 2008; 43: 490-6
|
|
|
|
|
|
12) Hayashi Y, Yamamoto H, Taguchi H, et al. Nonsteroidal anti-inflammatory drug-induced small-bowel lesions identified by double-balloon endoscopy: endoscopic features of the lesions and endoscopic treatments for diaphragm disease. J Gastroenterol. 2009; 44 Suppl 19: 57-63
|
|
|
|
|
|
13) De Petris G, Lopez JI. Histopathology of diaphragm disease of the small intestine: a study of 10 cases from a single institution. Am J Clin Pathol. 2008; 130: 518-25
|
|
|
|
|
|
14) Pilgrim S, Velchuru V, Waters G, et al. Diaphragm disease and small bowel enteropathy due to non-steroidal anti-inflammatory drugs; a surgical perspective. Colorectal Dis. 2009; [Epub ahead of print]
|
|
|
|
|
|
15) Goldstein JL, Eisen GM, Lewis B, et al. Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy. Aliment Pharmacol Ther. 2007; 25: 1211-22
|
|
|
|
|
|
16) Hawkey CJ, Ell C, Simon B, et al. Less small-bowel injury with lumiracoxib compared with naproxen plus omeprazole. Clin Gastroenterol Hepatol. 2008; 6: 536-44
|
|
|
|
|
|
17) Maiden L, Thjodleifsson B, Seigal A, et al. Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study. Clin Gastroenterol Hepatol. 2007; 5: 1040-5
|
|
|
|
|
|
18) Lapner MA, Stephen WJ. Rofecoxib associated with diaphragm disease. Can J Surg. 2007; 50: E27-8
|
|
|
|
|
|
19) Watanabe T, Sugimori S, Kameda N, et al. Small bowel injury by low-dose enteric-coated aspirin and treatment with misoprostol: a pilot study. Clin Gastroenterol Hepatol. 2008; 6: 1279-82
|
|
|
|
|
|
20) Fujimori S, Seo T, Gudis K, et al. Prevention of nonsteroidal anti-inflammatory drug-induced small-intestinal injury by prostaglandin: a pilot randomized controlled trial evaluated by capsule endoscopy. Gastrointest Endosc. 2009; 69: 1339-46
|
|
|
|
|
|
21) Niwa Y, Nakamura M, Ohmiya N, et al. Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study. J Gastroenterol. 2008; 43: 270-6
|
|
|
|
|
|
22) Asano T, Tanaka K, Yamakawa N, et al. HSP70 confers protection against indomethacin-induced lesions of the small intestine. J Pharmacol Exp Ther. 2009; 330: 458-67
|
|
|
|
|
|
23) Marchbank T, Limdi JK, Mahmood A, et al. Clinical trial: protective effect of a commercial fish protein hydrolysate against indomethacin (NSAID)-induced small intestinal injury. Aliment Pharmacol Ther. 2008; 28: 799-804
|
|
|
|
|
|
24) Satoh H, Hara T, Murakawa D, et al. Soluble dietary fiber protects against nonsteroidal anti-inflammatory drug-induced damage to the small intestine in cats. Dig Dis Sci. 2010; 55: 1264-71
|
|
|
|
|
|
25) Watanabe T, Nishio H, Tanigawa T, et al. Probiotic Lactobacillus casei strain Shirota prevents indomethacin-induced small intestinal injury: involvement of lactic acid. Am J Physiol Gastrointest Liver Physiol. 2009; 297: G506-13
|
|
|
|
|